|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ANZCTR |
|
Last refreshed on:
|
22 February 2013 |
|
Main ID: |
ACTRN12610000225011 |
|
Date of registration:
|
17/03/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Understanding asthma in older people
|
|
Scientific title:
|
Is asthma in the elderly a disease of the peripheral airways? An observational study measuring airway hyperresponsiveness |
|
Date of first enrolment:
|
1/04/2010 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://www.anzctr.org.au/ACTRN12610000225011.aspx |
|
Study type:
|
Observational |
|
Study design:
|
|
|
|
Countries of recruitment
|
|
Australia
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr Greg King |
|
Address:
|
Woolcock Institute of Medical Research,
PO Box M77,
Missenden Road PO,
Camperdown,
NSW, 2050, Australia
|
|
Telephone:
|
+61 2 9926 6265 |
|
Email:
|
ggk@woolcock.org.au |
|
Affiliation:
|
|
|
|
Name:
|
Dr Greg King |
|
Address:
|
Woolcock Institute of Medical Research,
PO Box M77,
Missenden Road PO,
Camperdown,
NSW, 2050, Australia
|
|
Telephone:
|
+61 2 9926 6265 |
|
Email:
|
ggk@woolcock.org.au |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Doctor diagnosed asthmatics
Exclusion criteria: Current smoking or history of smoking > 10 pack years, lung disease other than asthma, taking oral corticosteroids in last 4 weeks or having upper respiratory tract infection in last 4 weeks.
Age minimum:
18 Years
Age maximum:
100 Years
Gender:
Both males and females
|
|
Health Condition(s) or Problem(s) studied
|
|
Asthma
|
|
Intervention(s)
|
The predictors of airway hyperresponsiveness are being measured and compared with other measures of ventilation heterogeneity, lung elastic recoil, airway closure measured by lung imaging and lung volumes.
The study will last for 3 years, however each subject will complete 4 visits over 1-2 weeks.
|
|
Primary Outcome(s)
|
|
Airway hyperresponsiveness meaured using methacholine challenge
|
|
Source(s) of Monetary Support
|
|
National Health and Medical Research Council
|
|